PortfoliosLab logo

Adamis Pharmaceuticals Corporation (ADMP)

Equity · Currency in USD · Last updated Jan 27, 2023

Company Info

ISINUS00547W2089
CUSIP00547W208
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Trading Data

Previous Close$0.20
Year Range$0.13 - $0.67
EMA (50)$0.19
EMA (200)$0.32
Average Volume$622.59K
Market Capitalization$29.76M

ADMPShare Price Chart


Loading data...

ADMPPerformance

The chart shows the growth of $10,000 invested in Adamis Pharmaceuticals Corporation in Jan 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $368 for a total return of roughly -96.32%. All prices are adjusted for splits and dividends.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2023
-45.88%
-1.41%
ADMP (Adamis Pharmaceuticals Corporation)
Benchmark (^GSPC)

ADMPCompare to other instruments

Search for stocks, ETFs, and funds to compare with ADMP

ADMPReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD17.65%5.75%
1M25.00%5.61%
6M-44.44%0.92%
1Y-67.21%-6.79%
5Y-44.85%7.18%
10Y-33.37%10.46%

ADMPMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-1.64%6.67%-10.94%-31.58%25.64%2.04%-24.00%-13.16%-39.39%-30.00%42.86%-15.00%
2021137.06%-2.61%-16.07%-15.96%-12.66%59.42%7.27%-7.63%-11.01%8.25%-21.90%-25.61%
2020-5.75%-14.38%-36.78%45.54%-5.17%8.90%119.74%-44.07%18.70%-9.85%-38.64%11.95%
201936.44%-3.58%-28.72%-2.84%-26.34%-13.91%-11.54%-18.35%-24.97%14.98%-28.06%20.20%
2018-17.05%-17.81%16.67%2.86%19.44%-25.58%0.00%-10.94%22.81%-26.86%19.14%-26.23%
2017-1.59%11.29%23.19%-12.94%4.05%35.06%-11.54%18.48%-4.13%-0.48%-26.92%15.79%
2016-12.04%22.11%5.69%34.58%5.09%-67.70%0.36%4.98%16.27%-24.93%8.74%12.50%
201510.53%-5.87%-38.63%9.14%-0.70%-1.64%-0.24%-12.65%5.74%11.63%5.32%18.68%
20144.23%-0.15%-4.36%-14.78%4.34%-14.94%-21.62%6.63%16.42%0.21%-11.94%49.39%
2013-4.23%16.18%-16.46%-24.24%49.80%-11.88%-22.73%-19.61%-8.54%-6.67%12.86%-4.84%
2012-0.00%0.00%35.29%182.61%5.85%6.10%-17.81%-8.33%7.27%67.78%-9.08%-21.11%
2011-2.33%-14.29%3.33%23.66%-4.35%0.00%4.55%-15.22%7.69%14.29%-4.17%-26.09%
20109.38%14.29%-47.52%-9.48%-7.89%48.57%3.85%-1.85%-16.98%25.00%-9.09%-14.00%

ADMPSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Adamis Pharmaceuticals Corporation Sharpe ratio is -0.72. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20SeptemberOctoberNovemberDecember2023
-0.72
-0.28
ADMP (Adamis Pharmaceuticals Corporation)
Benchmark (^GSPC)

ADMPDividend History


Adamis Pharmaceuticals Corporation doesn't pay dividends

ADMPDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember2023
-98.88%
-15.35%
ADMP (Adamis Pharmaceuticals Corporation)
Benchmark (^GSPC)

ADMPWorst Drawdowns

The table below shows the maximum drawdowns of the Adamis Pharmaceuticals Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Adamis Pharmaceuticals Corporation is 99.27%, recorded on Oct 7, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.27%Nov 9, 20122495Oct 7, 2022
-70.59%Jan 14, 2010533Feb 27, 201241Apr 25, 2012574
-37.66%Jun 20, 201258Sep 11, 201228Oct 19, 201286
-32.65%May 2, 20127May 10, 201216Jun 4, 201223
-8.45%Apr 30, 20121Apr 30, 20121May 1, 20122
-7.89%Jun 6, 20122Jun 7, 20127Jun 18, 20129
-5%Oct 26, 20121Oct 26, 20123Nov 2, 20124
-4.69%Jan 5, 20101Jan 5, 20101Jan 6, 20102
-0.96%Nov 5, 20121Nov 5, 20121Nov 6, 20122

ADMPVolatility Chart

Current Adamis Pharmaceuticals Corporation volatility is 64.82%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%SeptemberOctoberNovemberDecember2023
64.82%
16.79%
ADMP (Adamis Pharmaceuticals Corporation)
Benchmark (^GSPC)